Publication Name	World Journal of Diabetes
Manuscript ID	113005
Country	China

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Minireviews
Article Title	Pharmacological management of major complications following left ventricular assist device implantation in type 2 diabetes mellitus
Manuscript Source	Invited Manuscript
All Author List	Ying-Lu Zhang, Wen-Yan Wang and Zhen-Yu Liu
Funding Agency and Grant Number
Corresponding Author	Zhen-Yu Liu, PhD, Professor, Department of Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, China., Shanghai 200025, China. liuzhenyu200210@sjtu.edu.cn
Key Words	Left ventricular assist devices; Type 2 diabetes mellitus; Heart failure; Pharmacological management; Bleeding
Core Tip	Type 2 diabetes mellitus exacerbates left ventricular assist device (LVAD)-related complications via endothelial dysfunction and inflammation. This review highlights tailored strategies, including precision warfarin dosing, aspirin omission from magnetically levitated LVADs, SGLT-2 inhibitors/GLP-1 agonists for glycemic control, and novel infection/right ventricular failure management to optimize outcomes.
Citation	Zhang YL, Wang WY, Liu ZY. Pharmacological management of major complications following left ventricular assist device implantation in type 2 diabetes mellitus. World J Diabetes 2025; In press

Received	2025-08-13 01:03
Peer-Review Started	2025-08-18 00:21
To Make the First Decision
Return for Revision	2025-09-07 02:56
Revised	2025-09-07 18:52
Second Decision	2025-10-11 02:32
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-10-20 10:13
Articles in Press	2025-10-20 10:13
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com